Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYSanthera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular DystrophyPREV STORYRevolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress